Founder & CSO, Ayma Therapeutics Inc.
Dr. Narayanan 'Suri' Surendran is a drug discovery and development professional with US and Indian Pharma industry background. He has over 24 years of experience and has contributed to 3 clinical candidates across various therapeutic areas. Dr. Surendran founded RythRx Therapeutics to develop novel transfusion medicine products. RythRx was awarded US patent for this technology in 2018.
CTO, Ayma Therapeutics Inc.
Mr. Ramesh Gopalan is also the Founder/President of Cognitive Mantra Inc. He has over 20 years of experience in delivering enterprise technology solutions. He is currently focused on developing advanced AI and Cognitive Computing solutions for the Pharma and Life Sciences industry.
Copyright © 2019 Ayma Therapeutics Inc. - All Rights Reserved.